(Q43672726)

25 November 2017

title

HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies (English)

1 reference

ORCID Public Data File 2021

25 November 2017

1 reference

1 reference

1 reference

author name string

Fischer T

1

1 reference

25 November 2017

Wallukat G

2

1 reference

25 November 2017

Schneider MP

3

1 reference

25 November 2017

Schlembach D

4

1 reference

25 November 2017

Munz W

5

1 reference

25 November 2017

Homuth V

6

1 reference

25 November 2017

publication date

1 August 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

25 November 2017

published in

1 reference

25 November 2017

volume

97

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

255-257

1 reference

Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

HELLP syndrome--a syndrome of hemolysis, elevated liver enzymes and low platelet count--complicating preeclampsia-eclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

1 reference

7 January 2021

Prognosis of children born to mothers with HELLP-syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

Temporising management of severe pre-eclampsia with and without the HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

Hypertensive disorders in twin pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900534-0

7 January 2021

10.1016/S0301-2115(00)00534-0

Identifiers

DOI

1 reference

25 November 2017

1 reference